Clinical Trial of Astaxanthin Formulation With Exercise in Sarcopenia Elderly

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Sarcopenia
Interventions
OTHER

Astaxanthin formulation

Astaxanthin formulation containing AstaReal® astaxanthin (Haematococcus pluvialis algae extract), tocotrienol, and zinc will be orally administered starting on Day 1 until Day 120

OTHER

Placebo

Placebo will be orally administered starting on Day 1 until Day 120.

OTHER

Exercise training

The subjects will undergo interval treadmill incline protocol (target 85% HR max, 3 times a week for 40 to 60 minutes) starting on Day 31 until Day 120.

Trial Locations (2)

98109

Fred Hutchinson Cancer Research Center Prevention Center, Seattle

98195

University of Washington Medical Center, Seattle

All Listed Sponsors
lead

Astavita, Inc.

INDUSTRY

NCT03368872 - Clinical Trial of Astaxanthin Formulation With Exercise in Sarcopenia Elderly | Biotech Hunter | Biotech Hunter